M. Patricia D’Souza
YOU?
Author Swipe
View article: An Integrated DAIDS Laboratory Oversight Framework: Application of the DAIDS GCLP Guidelines
An Integrated DAIDS Laboratory Oversight Framework: Application of the DAIDS GCLP Guidelines Open
The Division of AIDS (DAIDS) Good Clinical Laboratory Practice (GCLP) Guidelines establish a framework to guide the oversight of laboratories supporting DAIDS-sponsored clinical research or trials. Compliance with these guidelines promotes…
View article: Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV—workshop report
Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV—workshop report Open
The US National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institute of Health (NIH), convened a virtual workshop on August 8-9th, 2023 to explore potential synergies between HIV vaccine approaches that are …
View article: Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report Open
On November 7th and 8th, 2022, The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), The Coalition for Epidemic Preparedness Innovation (CEPI), The Bill & Melinda Gates Foundati…
View article: Leveraging lessons learned from the COVID-19 pandemic for HIV
Leveraging lessons learned from the COVID-19 pandemic for HIV Open
The rapid development of COVID-19 vaccines and their deployment in less than a year is an unprecedented scientific, medical, and public health achievement. This rapid development leveraged knowledge from decades of HIV/AIDS research and ad…
View article: Research productivity and collaboration of the NIH-funded HIV vaccine trials network: A bibliometric analysis
Research productivity and collaboration of the NIH-funded HIV vaccine trials network: A bibliometric analysis Open
The HIV Vaccine Trials Network (HVTN) is the world's largest publicly funded, multi-disciplinary international collaboration facilitating the development of vaccines to prevent HIV/AIDS and has conducted the vast majority of HIV/AIDS clini…
View article: Research productivity and collaboration of the NIH-funded HIV Vaccine Trials Network: a bibliometric analysis
Research productivity and collaboration of the NIH-funded HIV Vaccine Trials Network: a bibliometric analysis Open
Objectives To assess the scientific productivity and impact of the HIV Vaccine Trials Network (HVTN) over the last two decades and to examine how research collaboration has evolved over this time in the HIV vaccine field. Design This secti…
View article: Casting a wider net: Immunosurveillance by nonclassical MHC molecules
Casting a wider net: Immunosurveillance by nonclassical MHC molecules Open
Most studies of T lymphocytes focus on recognition of classical major histocompatibility complex (MHC) class I or II molecules presenting oligopeptides, yet there are numerous variations and exceptions of biological significance based on r…